Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2da3163deb44a60f9cad90ce6f350978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692b6800a6c3a699c4c5466eed1c6cef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4282b704b62f120ad453f0dbe568aa17 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
1996-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9dc650368130c1f5fd0382e6f76cf52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e700c324ce3745a6b5ebdd88b44d4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d39e4445241596c6ef906bfe16aa5b26 |
publicationDate |
1997-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9722972-A2 |
titleOfInvention |
Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule |
abstract |
The specification discloses combinatorial libraries of recombinant antibody-like molecules used to identify both potential therapeutic targets and their corresponding neutralizing antibody(ies). The identification can be done either by in vitro (biochemical) means or in situ with established cell lines. No prior knowledge of either the antigen target or its corresponding antibody is required. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1394550-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9834110-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0169247-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004021013-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-778776-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0014215-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6740492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0169247-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6727062-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0061790-A1 |
priorityDate |
1995-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |